官方服务：
资源简介：
A dataset describing the relationship between irAE and prognosis after immunotherapy for hepatocellular carcinoma
应用场景：
创建时间：
2022-09-08
相关数据集
Table_4_Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma.xlsx
Antibodies targeting the programmed cell death protein-1 (PD-1) molecule have been reported to hold promising antitumor activities in patients with nasopharyngeal carcinoma (NPC). However, only a smal
NIAID Data Ecosystem50
Table_1_Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric Cancer.XLSX
Gastric cancer (GC) is a serious malignant tumor with high mortality and poor prognosis. The prognosis and survival are much worse for advanced gastric cancer (AGC). Recently, immunotherapy has been w
NIAID Data Ecosystem20
Determination of ABO blood type for prostate cancer patients. Homo sapiens
Purpose: This study uses a high-throughput glycan microarray to assign ABO blood type to patients from a clinical trial on PROSTVAC. The goal is to determine if blood type correlates with survival for
NIAID Data Ecosystem20
Proteomic profiling of advanced melanoma to predict therapeutic response to anti-PD-1 therapy
Despite high clinical need, hardly any biomarker can accurately predict if patients with metastatic melanoma will respond to anti-PD-1 therapy. In this multicenter study we applied depletion and enric
NIAID Data Ecosystem20
Table_2_Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma.XLSX
Background: Melanoma is highly immunogenic and therefore suitable for immunotherapy, but the efficacy is limited by response rate. In several types of tumor, tumor mutation burden (TMB) and immune inf
NIAID Data Ecosystem20
